Denmark· DK-28106723920
Imoxat til små hunde (op til 4 kg)
A moksidektiini, yhdistelmävalmisteet product containing imidacloprid, moxidectin, registered in Denmark by Chanelle Pharmaceuticals Manufacturing Limited. The same ATC class is registered in 2 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Imidacloprid, moxidectin is registered in 2 of 19 countries.
Countries holding a registration under ATC QP54AB52 (moksidektiini, yhdistelmävalmisteet), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 1 of them publish a price we can compare per daily dose
Imidacloprid, moxidectin · ATC QP54AB52
2 / 19 countries
- Denmark
- Finlandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Imidacloprid, Moxidectin
- Manufacturer
- Chanelle Pharmaceuticals Manufacturing Limited
- Country
- Denmark (DK)
- ATC code
- QP54AB52
- ATC class
- Moksidektiini, yhdistelmävalmisteet
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106723920
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under QP54AB52
Moksidektiini, yhdistelmävalmisteet, as other registers publish it.
- FinlandAdvocateElanco Animal Health GmbH
- FinlandAdvocateElanco Animal Health GmbH
- FinlandAdvocateElanco Animal Health GmbH
- FinlandAdvocateElanco Animal Health GmbH
- FinlandAdvocateElanco Animal Health GmbH
- FinlandAdvocateElanco Animal Health GmbH
- DenmarkAdvocate til ekstra store hundeElanco Animal Health GmbH
- DenmarkAdvocate til mellemstore hundeElanco Animal Health GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eca45524-0c95-467b-bc41-5f6bfa368bb4 GET /v1/drugs/eca45524-0c95-467b-bc41-5f6bfa368bb4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "spot-on, opløsning",
"source": "dkma",
"strength": "100+25 mg/ml i 0,4 ml",
"auth_role": "MOD",
"dk_drugid": "28106723920",
"substance": "Imidacloprid, Moxidectin",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "44537"
}See everything about imidacloprid, moxidectin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.